277 related articles for article (PubMed ID: 35420163)
1. An overview of mutational and copy number signatures in human cancer.
Steele CD; Pillay N; Alexandrov LB
J Pathol; 2022 Jul; 257(4):454-465. PubMed ID: 35420163
[TBL] [Abstract][Full Text] [Related]
2. Signatures of copy number alterations in human cancer.
Steele CD; Abbasi A; Islam SMA; Bowes AL; Khandekar A; Haase K; Hames-Fathi S; Ajayi D; Verfaillie A; Dhami P; McLatchie A; Lechner M; Light N; Shlien A; Malkin D; Feber A; Proszek P; Lesluyes T; Mertens F; Flanagan AM; Tarabichi M; Van Loo P; Alexandrov LB; Pillay N
Nature; 2022 Jun; 606(7916):984-991. PubMed ID: 35705804
[TBL] [Abstract][Full Text] [Related]
3. SigProfilerMatrixGenerator: a tool for visualizing and exploring patterns of small mutational events.
Bergstrom EN; Huang MN; Mahto U; Barnes M; Stratton MR; Rozen SG; Alexandrov LB
BMC Genomics; 2019 Aug; 20(1):685. PubMed ID: 31470794
[TBL] [Abstract][Full Text] [Related]
4. Analysis of mutational signatures in C. elegans: Implications for cancer genome analysis.
Meier B; Volkova NV; Gerstung M; Gartner A
DNA Repair (Amst); 2020 Nov; 95():102957. PubMed ID: 32980770
[TBL] [Abstract][Full Text] [Related]
5. Copy-number intratumor heterogeneity increases the risk of relapse in chemotherapy-naive stage II colon cancer.
Lahoz S; Archilla I; Asensio E; Hernández-Illán E; Ferrer Q; López-Prades S; Nadeu F; Del Rey J; Sanz-Pamplona R; Lozano JJ; Castells A; Cuatrecasas M; Camps J
J Pathol; 2022 May; 257(1):68-81. PubMed ID: 35066875
[TBL] [Abstract][Full Text] [Related]
6. Recent Advances in Pathology: the 2022 Annual Review Issue of The Journal of Pathology.
Herrington CS; Poulsom R; Pillay N; Bankhead P; Coates PJ
J Pathol; 2022 Jul; 257(4):379-382. PubMed ID: 35635736
[TBL] [Abstract][Full Text] [Related]
7. Topography of mutational signatures in human cancer.
Otlu B; Díaz-Gay M; Vermes I; Bergstrom EN; Zhivagui M; Barnes M; Alexandrov LB
Cell Rep; 2023 Aug; 42(8):112930. PubMed ID: 37540596
[TBL] [Abstract][Full Text] [Related]
8. The repertoire of copy number alteration signatures in human cancer.
Tao Z; Wang S; Wu C; Wu T; Zhao X; Ning W; Wang G; Wang J; Chen J; Diao K; Chen F; Liu XS
Brief Bioinform; 2023 Mar; 24(2):. PubMed ID: 36806386
[TBL] [Abstract][Full Text] [Related]
9. Copy number signature analysis tool and its application in prostate cancer reveals distinct mutational processes and clinical outcomes.
Wang S; Li H; Song M; Tao Z; Wu T; He Z; Zhao X; Wu K; Liu XS
PLoS Genet; 2021 May; 17(5):e1009557. PubMed ID: 33945534
[TBL] [Abstract][Full Text] [Related]
10. Mutational spectra and mutational signatures: Insights into cancer aetiology and mechanisms of DNA damage and repair.
Phillips DH
DNA Repair (Amst); 2018 Nov; 71():6-11. PubMed ID: 30236628
[TBL] [Abstract][Full Text] [Related]
11. The repertoire of mutational signatures in human cancer.
Alexandrov LB; Kim J; Haradhvala NJ; Huang MN; Tian Ng AW; Wu Y; Boot A; Covington KR; Gordenin DA; Bergstrom EN; Islam SMA; Lopez-Bigas N; Klimczak LJ; McPherson JR; Morganella S; Sabarinathan R; Wheeler DA; Mustonen V; ; Getz G; Rozen SG; Stratton MR;
Nature; 2020 Feb; 578(7793):94-101. PubMed ID: 32025018
[TBL] [Abstract][Full Text] [Related]
12. Novel insights into breast cancer copy number genetic heterogeneity revealed by single-cell genome sequencing.
Baslan T; Kendall J; Volyanskyy K; McNamara K; Cox H; D'Italia S; Ambrosio F; Riggs M; Rodgers L; Leotta A; Song J; Mao Y; Wu J; Shah R; Gularte-Mérida R; Chadalavada K; Nanjangud G; Varadan V; Gordon A; Curtis C; Krasnitz A; Dimitrova N; Harris L; Wigler M; Hicks J
Elife; 2020 May; 9():. PubMed ID: 32401198
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms underlying mutational signatures in human cancers.
Helleday T; Eshtad S; Nik-Zainal S
Nat Rev Genet; 2014 Sep; 15(9):585-98. PubMed ID: 24981601
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of mutational signatures of unknown etiology.
Hu X; Xu Z; De S
NAR Cancer; 2020 Sep; 2(3):zcaa026. PubMed ID: 33015626
[TBL] [Abstract][Full Text] [Related]
15. Unraveling the genomic landscape of colorectal cancer through mutational signatures.
Díaz-Gay M; Alexandrov LB
Adv Cancer Res; 2021; 151():385-424. PubMed ID: 34148618
[TBL] [Abstract][Full Text] [Related]
16. Copy-number intratumor heterogeneity as high-risk feature of stage II colon cancer
van den Bosch T; Miedema DM; Vermeulen L
J Pathol; 2022 Aug; 257(5):575-578. PubMed ID: 35470895
[TBL] [Abstract][Full Text] [Related]
17. Multiregional whole-genome sequencing of hepatocellular carcinoma with nodule-in-nodule appearance reveals stepwise cancer evolution.
Takeda H; Takai A; Kumagai K; Iguchi E; Arasawa S; Eso Y; Shimizu T; Ueda Y; Taura K; Uemoto S; Kita R; Haga H; Marusawa H; Fujimoto A; Seno H
J Pathol; 2020 Dec; 252(4):398-410. PubMed ID: 32815153
[TBL] [Abstract][Full Text] [Related]
18. Decoding whole-genome mutational signatures in 37 human pan-cancers by denoising sparse autoencoder neural network.
Pei G; Hu R; Dai Y; Zhao Z; Jia P
Oncogene; 2020 Jul; 39(27):5031-5041. PubMed ID: 32528130
[TBL] [Abstract][Full Text] [Related]
19. Intraindividual genomic heterogeneity of high-grade serous carcinoma of the ovary and clinical utility of ascitic cancer cells for mutation profiling.
Choi YJ; Rhee JK; Hur SY; Kim MS; Lee SH; Chung YJ; Kim TM; Lee SH
J Pathol; 2017 Jan; 241(1):57-66. PubMed ID: 27741368
[TBL] [Abstract][Full Text] [Related]
20. Cancer Mutational Processes Vary in Their Association with Replication Timing and Chromatin Accessibility.
Yaacov A; Vardi O; Blumenfeld B; Greenberg A; Massey DJ; Koren A; Adar S; Simon I; Rosenberg S
Cancer Res; 2021 Dec; 81(24):6106-6116. PubMed ID: 34702725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
